Literature DB >> 3128535

Induction of kappa light chain synthesis in 70Z/3 B lymphoma cells by chemically defined lipid A precursors.

C H Sibley1, A Terry, C R Raetz.   

Abstract

The murine B cell lymphoma 70Z/3 is a tumor line that resembles an early B cell. It responds to lipopolysaccharide by synthesizing kappa light chains, resulting in the appearance of surface IgM. We now demonstrate that this effect is triggered by the lipid A domain of lipopolysaccharide since a defined tetraacyl disaccharide 1,4'-bisphosphate precursor of mature lipid A, designated lipid IVA (Raetz, C. R. H., Purcell, S., Meyer, M. V., Qureshi, N., and Takayama, K. (1985) J. Biol. Chem. 260, 16080-16088), is fully active in stimulating kappa chain mRNA synthesis. In contrast, the monosaccharide lipid A precursor, lipid X, shows only slight activity; but a large excess of lipid X appears to complete with lipid IVA, partially blocking its effects. Mutants of the 70Z/3 line that are unresponsive to lipopolysaccharide also fail to respond to lipid IVA. The somatic cell system described here, coupled with the use of chemically defined agonists and antagonists, offers a new approach to understanding the early events in lipopolysaccharide/animal cell interactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Lipopolysaccharide and its analog antagonists display differential serum factor dependencies for induction of cytokine genes in murine macrophages.

Authors:  P Y Perera; N Qureshi; W J Christ; P Stütz; S N Vogel
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction.

Authors:  S H Zuckerman; N Qureshi
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

3.  Hypothermic response of mice to ornithine-containing lipids and to endotoxin.

Authors:  Y Kawai; N Takasuka; K Akagawa; S Naito
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.

Authors:  M V Norgard; L L Arndt; D R Akins; L L Curetty; D A Harrich; J D Radolf
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin.

Authors:  J D Lee; V Kravchenko; T N Kirkland; J Han; N Mackman; A Moriarty; D Leturcq; P S Tobias; R J Ulevitch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice.

Authors:  N Qureshi; K Takayama; R Kurtz
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

7.  Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS.

Authors:  T N Kirkland; N Qureshi; K Takayama
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Protection of mice from lethal endotoxemia by use of an ornithine-containing lipid or a serine-containing lipid.

Authors:  Y Kawai; K Kaneda; Y Morisawa; K Akagawa
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Macrophage activation by an ornithine-containing lipid or a serine-containing lipid.

Authors:  Y Kawai; K Akagawa
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

10.  CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition.

Authors:  R L Delude; R Savedra; H Zhao; R Thieringer; S Yamamoto; M J Fenton; D T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.